Join to View Full Profile
875 Blake Wilbur DrStanford Radiation OncologyStanford, CA 94305
Phone+1 650-736-7143
Dr. Loo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- As the Director of Thoracic Radiation Oncology at Stanford, my clinical specialty is radiation therapy of lung and other thoracic cancers.
My clinical research focus is on clinical trials and clinical translation of advanced high-precision 4-D image-guided radiation therapy and stereotactic ablative radiotherapy (SABR), as well as novel indications of SABR such as severe pulmonary emphysema. I also conduct preclinical and translational research in novel functional and metabolic imaging and imaging biomarkers.
I am principal investigator of the FLASH Sciences Lab @Stanford, a multidisciplinary preclinical research program to study the radiobiology of ultra-rapid FLASH irradiation and the development of technologies to conduct preclinical research and translate FLASH to the clinic.
https://profiles.stanford.edu/Billy_Loo
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 2001 - 2005
Kaiser Permanente Northern California (San Francisco)Internship, Internal Medicine, 2000 - 2001
University of California, Davis, School of MedicineClass of 2000, MD
University of California, San Francisco & BerkeleyPhD, Bioengineering, 2000
Certifications & Licensure
CA State Medical License 2001 - 2027
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer Start of enrollment: 2000 Mar 01
- Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation Start of enrollment: 2002 Nov 01
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers Start of enrollment: 1998 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Association Between Inter-Fraction Volume Changes and Patient Outcomes from Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer.Wilson X Mai, Melissa A Frick, Scott Jackson, Sara A Richter, Mohammad Hasan
Clinical Lung Cancer. 2025-10-25 - Efficacy and toxicity of hyperfractionated thoracic reirradiation.Santino S Butler, Tyler Raclin, Brianna Lau, Neelufar Raja, Lawrie Skinner
Radiotherapy and Oncology. 2025-08-01 - 3 citationsThymomas and Thymic Carcinomas, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.Gregory J Riely, Douglas E Wood, Billy W Loo, Dara L Aisner, Wallace Akerley
Journal of the National Comprehensive Cancer Network. 2025-06-01
Press Mentions
New Drugs Show Promise in Tough-to-Treat CancersOctober 22nd, 2025- How a High-Tech Chair Could Revolutionize Cancer Radiation TherapyOctober 16th, 2025
Billy Loo: “FLASH” Radiation Therapy Brings Hope to Cancer PatientsMarch 5th, 2019- Join now to see all
Grant Support
- Imaging and circulating DNA markers to assess early response and predict treatment failure patterns in lung cancerSTANFORD UNIVERSITY2019–2024
Professional Memberships
- Fellow
- International Association for the Study of Lung CancerMember
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
